{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:26:58Z","timestamp":1753892818553,"version":"3.41.2"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Cannabis use is common among patients with psychosis, and along with negative beliefs about medication, it has been found to predict poor adherence to antipsychotic drug treatment. Such lack of adherence to antipsychotic drug treatment increases the risk of poor clinical outcomes and relapse in patients with first treatment for psychosis (FTP). However, to date, it is unclear whether cannabis use may be related to negative perceptions about antipsychotic drug treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional sample of 265 FTP patients with schizophrenia spectrum disorder underwent extensive clinical assessments. Three measures of cannabis use were obtained: lifetime, current and meeting diagnostic criteria for abuse or addiction. For the primary analyses we focused on lifetime cannabis use. The Beliefs about Medication Questionnaire (BMQ) was employed to assess the patients' specific concerns and perceptions of antipsychotic medications, as well as general beliefs about pharmacotherapy. The relationship between lifetime cannabis use and BMQ scores was investigated with general linear model (GLM) analyses, controlling for age and sex.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with lifetime use of cannabis \u226510 times were more likely to be male, younger at the age of onset of psychosis and with higher levels of alcohol use and daily tobacco smoking, as compared to the non-users (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). Neither lifetime use of cannabis, current use nor a cannabis abuse diagnosis was associated with negative beliefs about medicines as measured by the BMQ questionnaire.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Use of cannabis is not linked to negative perceptions about antipsychotic medicines in patients with FTP. Other reasons for poor compliance to antipsychotic drug treatment in cannabis users need to be further investigated.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2022.824051","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:40:15Z","timestamp":1648611615000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Priyanthi B.","family":"Gjerde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Synne W.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trude S. J.","family":"Vedal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils Eiel","family":"Steen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elina J.","family":"Reponen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidar M.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Melle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1001\/jama.264.19.2511","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1600-0447.2006.00900.x","article-title":"Patterns, predictors and impact of substance use in early psychosis: a longitudinal study","volume":"115","author":"Addington","year":"2007","journal-title":"Acta Psychiatr Scand."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/schbul\/sbp031","article-title":"Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis","volume":"36","author":"Koskinen","year":"2010","journal-title":"Schizophr Bull."},{"key":"B4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.schres.2017.04.046","article-title":"The interaction of gender and cannabis in early phase psychosis","volume":"194","author":"Crocker","year":"2018","journal-title":"Schizophr Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00213-013-3157-y","article-title":"Cannabis use and cognitive functions in at-risk mental state and first episode psychosis","volume":"230","author":"Bugra","year":"2013","journal-title":"Psychopharmacology (Berl)."},{"key":"B6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1192\/bjp.bp.104.007237","article-title":"Comorbid substance use and age at onset of schizophrenia","volume":"188","author":"Barnes","year":"2006","journal-title":"Br J Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.schres.2015.11.027","article-title":"Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119)","volume":"170","author":"Helle","year":"2016","journal-title":"Schizophr Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1001\/archgenpsychiatry.2010.6","article-title":"Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults","volume":"67","author":"McGrath","year":"2010","journal-title":"Arch Gen Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","article-title":"Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis","volume":"3","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry."},{"key":"B10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/eip.12542","article-title":"Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients experiencing first episode psychosis: data from the national RAISE-ETP study","volume":"13","author":"Oluwoye","year":"2019","journal-title":"Early Interv Psychiatry."},{"key":"B11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/archgenpsychiatry.2011.5","article-title":"Cannabis use and earlier onset of psychosis: a systematic meta-analysis","volume":"68","author":"Large","year":"2011","journal-title":"Arch Gen Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1017\/S0033291707009956","article-title":"The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study","volume":"37","author":"Degenhardt","year":"2007","journal-title":"Psychol Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1176\/appi.ajp.2009.09030311","article-title":"Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients","volume":"166","author":"Compton","year":"2009","journal-title":"Am J Psychiatry."},{"key":"B14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet (London, England)."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1136\/bmj.325.7374.1199","article-title":"Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study","volume":"325","author":"Zammit","year":"2002","journal-title":"BMJ."},{"key":"B16","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/schbul\/sbq153","article-title":"The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia","volume":"38","author":"Leeson","year":"2012","journal-title":"Schizophr Bull."},{"key":"B17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/schbul\/sbs188","article-title":"Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend","volume":"39","author":"Stefanis","year":"2013","journal-title":"Schizophr Bull."},{"key":"B18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1176\/appi.ajp.161.3.501","article-title":"Cannabis use and age at onset of schizophrenia","volume":"161","author":"Veen","year":"2004","journal-title":"Am J Psychiatry."},{"key":"B19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.psychres.2006.10.001","article-title":"Cannabis abuse and risk for psychosis in a prodromal sample","volume":"151","author":"Kristensen","year":"2007","journal-title":"Psychiatry Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1017\/S0033291714000117","article-title":"Cannabis use and transition to psychosis in people at ultra-high risk","volume":"44","author":"Valmaggia","year":"2014","journal-title":"Psychol Med."},{"key":"B21","first-page":"3","article-title":"Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia","volume":"67","author":"Leucht","year":"2006","journal-title":"J Clin Psychiatry."},{"key":"B22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4088\/PCC.08r00612","article-title":"Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review","volume":"11","author":"Masand","year":"2009","journal-title":"Prim Care Companion J Clin Psychiatry."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1017\/S0033291717000046","article-title":"Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis","volume":"47","author":"Foglia","year":"2017","journal-title":"Psychol Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/schbul\/23.4.637","article-title":"Determinants of medication compliance in schizophrenia: empirical and clinical findings","volume":"23","author":"Fenton","year":"1997","journal-title":"Schizophr Bull."},{"key":"B25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1034\/j.1600-0447.2002.02437.x","article-title":"Medication adherence of individuals with a first episode of psychosis","volume":"106","author":"Coldham","year":"2002","journal-title":"Acta Psychiatr Scand."},{"key":"B26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.schres.2009.04.018","article-title":"A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia","volume":"113","author":"Miller","year":"2009","journal-title":"Schizophr Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"J Clin Psychiatry."},{"key":"B28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1600-0447.2008.01279.x","article-title":"Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders","volume":"119","author":"Jonsdottir","year":"2009","journal-title":"Acta Psychiatr Scand."},{"key":"B29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J Psychosom Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/15622975.2016.1245441","article-title":"Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders","volume":"18","author":"Steen","year":"2017","journal-title":"World J Biol Psychiatry."},{"volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000","key":"B31"},{"key":"B32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull."},{"key":"B33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0920-9964(92)90003-N","article-title":"Reliability and validity of a depression rating scale for schizophrenics","volume":"6","author":"Addington","year":"1992","journal-title":"Schizophr Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.comppsych.2006.03.008","article-title":"Generalizability studies of the Global Assessment of Functioning-Split version","volume":"48","author":"Pedersen","year":"2007","journal-title":"Compr Psychiatry."},{"key":"B35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2013II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction."},{"key":"B36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00406-011-0188-4","article-title":"Excessive cannabis use is associated with earlier age at onset in bipolar disorder","volume":"261","author":"Lagerberg","year":"2011","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/PPA.S124658","article-title":"Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness","volume":"11","author":"Velligan","year":"2017","journal-title":"Patient Prefer Adherence."},{"key":"B38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.schres.2011.07.019","article-title":"Are we addressing the \u201cright stuff\u201d to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication","volume":"132","author":"Beck","year":"2011","journal-title":"Schizophr Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/0004867414525838","article-title":"Systematic meta-analysis of outcomes associated with psychosis and co-morbid substance use","volume":"48","author":"Large","year":"2014","journal-title":"Aust N Z J Psychiatry."},{"key":"B40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.schres.2012.07.023","article-title":"Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis","volume":"141","author":"Faridi","year":"2012","journal-title":"Schizophr Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1192\/bjp.bp.106.024448","article-title":"Substance use in a population-based clinic sample of people with first-episode psychosis","volume":"190","author":"Barnett","year":"2007","journal-title":"Br J Psychiatry."},{"key":"B42","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.comppsych.2013.08.018","article-title":"One year follow-up of alcohol and illicit substance use in first-episode psychosis: does gender matter?","volume":"55","author":"Lange","year":"2014","journal-title":"Compr Psychiatry."},{"key":"B43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3109\/09540261.2010.515205","article-title":"Sex differences in schizophrenia","volume":"22","author":"Abel","year":"2010","journal-title":"Int Rev Psychiatry."},{"key":"B44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-0447.2011.01763.x","article-title":"Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis","volume":"125","author":"Dragt","year":"2012","journal-title":"Acta Psychiatr Scand."},{"key":"B45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.schres.2008.08.008","article-title":"Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis","volume":"106","author":"Corcoran","year":"2008","journal-title":"Schizophr Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/acps.12382","article-title":"Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample","volume":"132","author":"Auther","year":"2015","journal-title":"Acta Psychiatr Scand."},{"key":"B47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jpsychires.2016.10.022","article-title":"Smoking status and its relationship to demographic and clinical characteristics in first episode psychosis","volume":"85","author":"Grossman","year":"2017","journal-title":"J Psychiatr Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1017\/S0033291712000062","article-title":"Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender","volume":"42","author":"Dekker","year":"2012","journal-title":"Psychol Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.psychres.2013.06.010","article-title":"Current cannabis use and age of psychosis onset: a gender-mediated relationship? Results from an 8-year FEP incidence study in Bologna","volume":"210","author":"Allegri","year":"2013","journal-title":"Psychiatry Res."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.824051\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:40:19Z","timestamp":1648611619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.824051\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":49,"alternative-id":["10.3389\/fpsyt.2022.824051"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.824051","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2022,3,29]]},"article-number":"824051"}}